<?xml version="1.0" encoding="UTF-8"?>
<p>Yang et al (2020)
 <xref rid="ger12499-bib-0013" ref-type="ref">
  <sup>13</sup>
 </xref> assessed the prevalence of co‐morbidities in SARS‐CoV‐2 infected patients and concluded that the risk is greater among individuals with hypertension, diabetes, cardiovascular and respiratory disorders in decreasing order. In addition to these co‐morbidities, ageing patients undergoing chemotherapy, radiotherapy, prolonged corticosteroid therapy and organ transplantation are risk‐prone for SARS‐CoV‐2 infection due to their suppressed immune status.
</p>
